GSK Plans 10,000 Doses Of Ebola Vaccine

The global pharmaceutical giant, GSK, plans to manufacture ten thousand doses of its experimental Ebola vaccine following the commencement yesterday in the UK of human trials of the medicine.
As it were, the world is pinning its hopes on the vaccine to contain an unprecedented outbreak in parts of West Africa.
The aim is to have the 10,000 doses of the experimental vaccine ready so that if the ongoing human trials are successful, stocks can be made available immediately to the World Health Organisation (WHO) to fortify health workers who are high risk of being infected.
Britain’s trial of an experimental vaccine against Ebola began in Oxford yesterday with the first healthy volunteer receiving the vaccine.
Ruth Atkins, 48, was injected with the candidate Ebola vaccine on Wednesday after a clinical assessment. She was the first of 60 volunteers to participate in the trial.

About Author

This is BizWatchNigeria. Nigeria's first online business Newspaper.

Comment here

This site uses Akismet to reduce spam. Learn how your comment data is processed.